{
    "nct_id": "NCT06600152",
    "official_title": "A Randomized, Open-label, Investigational Safety Evaluation of the Microporous Annealed Particle (MAP) Wound Matrix (TT101) Device As a Volumetric Biomaterial Scaffold Applied to Clean Wounds After Skin Cancer Surgery with Mohs Micrographic Surgery (MMS) Compared to Control.",
    "inclusion_criteria": "* Willing to undergo the written informed consent process prior to enrollment in this study.\n* At least 22 years of age at screening.\n* Has non-melanoma skin cancer and be scheduled for skin cancer surgery with Mohs micrographic surgery on a location suitable for secondary intention healing.\n* Resulting surgical wound after Mohs micrographic surgery must be at least 1 cm and no more than 4 cm in diameter (or surface area of at least 0.8 cm2 and no more than 12.6 cm2).\n* Resulting surgical wound after Mohs micrographic surgery must be full thickness.\n* Willing to return for all required follow-up visits.\n* Willing to follow the instructions of the Principal Investigator.\nHealthy volunteers allowed\nMust have minimum age of 22 Years",
    "exclusion_criteria": "_ Has a confirmed diagnosis of clinically significant peripheral neuropathy.\n\n* Has uncontrolled Type I or Type II diabetes and HbA1c values greater than 8.0% within the last 6 months.\n* Has a known infection in the area of the Mohs micrographic surgery.\n* Has a known allergy to any of the components of the TT101 Device.\n* Is an active daily cigarette smoker.\n* Is pregnant or lactating.\n* Is a woman of child-bearing potential who is unwilling to avoid pregnancy or use an appropriate form of birth control (adequate birth control methods are defined as: topical, oral, implantable, or injectable contraceptives; spermicide in conjunction with a barrier such as a condom or diaphragm; IUD; or surgical sterilization of partner).\n* Has clinical evidence of Peripheral Vascular Disease (PVD) in the form of grade 2 pitting Edema or higher.\n* Has been diagnosed with a surgical or wound site infection within the last 6-months.\n* Has been diagnosed with chronic ulcer or wound within the last 12- months.\n* Has a remote active infection concurrent with having the Mohs micrographic surgery.\n* Per Investigator's discretion the subject is not appropriate for inclusion in the trial.",
    "miscellaneous_criteria": ""
}